Non-Functioning Endocrine Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Non-Functioning Endocrine Neoplasm

cancer family

Identifier: CI-CAN-00000290
Entity page: /cancer/non-functioning-endocrine-neoplasm ↗
Edges: 18

Neighbours: 7 drugs11 trials
Drawn: 18 of 18 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Non-Functioning Endocrine Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived7 of 7
→ investigated in trials for	Cabozantinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Non-Functioning Endocrine Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Non-Functioning Endocrine Neoplasm studied in …STUDIED_INderived11 of 11show fewer
→ studied in	NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT04665739Phase 2 · recruiting Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 11 trials mapped (2 active)	—	—	Non-Functioning Lung Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05005715Phase 2 · completed Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03084770unknown Asymptomatic Small Pancreatic Endocrine Neoplasms. · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05907824unknown Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03918759completed Diagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENs · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05566093NA · unknown EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02420691Phase 2 · completed Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT01283542Phase 2 · completed Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02759718Phase 4 · unknown Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 11 trials mapped (2 active)	—	—	Non-Functioning Pancreatic Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →